GMRS — GMR Solutions Inc. stock price, charts and financials

NYSE·Healthcare·Medical - Care Facilities·USA

Latest market price

12.53

-0.13-1.03%

Overview Short InterestFilings

GMRSQT54GMR Solutions Inc.·NYSE

Overview Short InterestFilings

12.53-1.03%

Filing

Down 1.0% — Filed an 8-K material-event report (2026-09-17) — details in the filing.

Medium confidence

Loading chart...

Signal & projected range

Insider selling clusterHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

TALK+0.00%$5.25 TOI+0.78%$5.17 SRTA-0.74%$5.34 CYH-1.71%$2.87 AUNA-0.78%$5.10 USPH-0.73%$82.47 AMN-0.84%$34.26 VMD-0.45%$8.91

Snapshot

Index	-	P/E	8.64	EPS (ttm)	1.45	Insider Own	13.57%	Shs Outstand	54.01M	Perf Week	-1.96%

Market Cap	676.77M	Forward P/E	7.10	EPS next Y	1.77	Insider Trans	-32.10%	Shs Float	32.95M	Perf Month	-13.11%

Enterprise Value	5.28B	PEG	0.85	EPS next Q	-	Inst Own	-	Short Float	9.82%	Perf Quarter	-5.43%

Income	206.00M	P/S	0.12	EPS this Y	19.27%	Inst Trans	-	Short Ratio	4.39	Perf Half Y	-

Sales	5.74B	P/B	3.32	EPS next Y	2.12%	ROA	1.05%	Short Interest	3.24M	Perf YTD	-7.19%

Book/sh	3.78	P/C	0.98	EPS next 5Y	10.14%	ROE	15.58%	52W High	15.98 -21.59%	Perf Year	-

Cash/sh	12.74	P/FCF	10.68	EPS past 3/5Y	-	ROIC	2.78%	52W Low	10.26 22.12%	Perf 3Y	-

Dividend Est.	-	EV/EBITDA	4.94	Sales past 3/5Y	-	Gross Margin	31.25%	Volatility	5.81% 5.68%	Perf 5Y	-

Dividend TTM	-	EV/Sales	0.92	EPS Y/Y TTM	-	Oper. Margin	9.91%	ATR (14)	0.80	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	1.88	Sales Y/Y TTM	-	Profit Margin	2.65%	RSI (14)	45.27	Recom	2.25

Dividend Gr. 3/5Y	-	Current Ratio	2.01	EPS Q/Q	-	SMA20	-3.04%	Beta	0.03	Target Price	19.67

Payout	0.00%	Debt/Eq	25.95	Sales Q/Q	-	SMA50	-4.41%	Rel Volume	7.65	Prev Close	12.66

Employees	34,000	LT Debt/Eq	25.23	Earnings	Sep 07	SMA200	-3.76%	Avg Volume	788.72K	Price	12.53

IPO Date	May 12, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	-	Net Debt/EBITDA	9.51	Volume	6,034,044	Change	-1.03%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Aug-18-26	Reiterated	Goldman Sachs		$35 → $30
Jun-08-26	Initiated	Barclays	Overweight	$16
Jun-08-26	Reiterated	Needham		$18
Jun-08-26	Initiated	Morgan Stanley	Equal Weight	$14
Jun-08-26	Initiated	UBS	Buy	$20
Jun-08-26	Initiated	Goldman Sachs	Buy	$35
Jun-07-26	Initiated	Evercore ISI	Outperform	$20

Latest News· Times ET

Sep-17-26

Sep-17-2612:42PM

GMR Solutions Inc. Completes Term Loan Refinancing and $200 Million Debt Repaymentbusinesswire.com

12:42AM

Brian Scott Tierney Sells 265,794 Shares of GMR Solutions (NYSE:GMRS) Stockdefenseworld.net

12:11AM

Nicola Loporcaro Sells 1,457,102 Shares of GMR Solutions (NYSE:GMRS) Stockdefenseworld.net

Sep-14-26

Sep-14-2612:31PM

GMR Solutions Inc. (GMRS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcriptseekingalpha.com

Sep-11-26

Sep-11-2601:16PM

GMR Solutions Announces $200M Debt Repayment And Term Loan Repricing, Expects To Save $28M AnnuallyBenzinga

01:10PM

GMR Solutions Inc. Secures Commitments for Term Loan Repricing; Plans $200 Million Debt Paydownbusinesswire.com

Sep-03-26

Sep-03-2602:24PM

GMR Solutions Inc. to Present at September Conferencebusinesswire.com

Aug-13-26

Aug-13-2609:05PM

GMR Solutions Q2 Earnings Call Highlightsmarketbeat.com

10:17AM

GMR Solutions Inc. (GMRS) Q2 2026 Earnings Call Transcriptseekingalpha.com

Aug-12-26

Aug-12-2607:32PM

GMR Solutions Inc. (GMRS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimateszacks.com

12:30PM

GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidancebusinesswire.com

Aug-04-26

Aug-04-2605:53AM

GMR Solutions (GMRS) Price Target Increased by 14.29% to 20.40Fintel

Jul-23-26

Jul-23-2604:06AM

12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga

Jul-22-26

Jul-22-2604:00AM

GMR Solutions Inc. Sets Second Quarter 2026 Earnings Callbusinesswire.com

Jul-08-26

Jul-08-2604:30AM

GMR Solutions Strengthens Board with Appointments of Healthcare Leaders Dr. Amar Desai and Ellen Zanebusinesswire.com

Company

GMR Solutions Inc., headquartered in Lewisville, Texas, is a leading U.S.-based company specializing in comprehensive out-of-hospital healthcare and mobile clinical services. The organization delivers both emergency and non-emergency medical care. Beyond direct patient transport and treatment, their service portfolio extends to include tailored membership programs, dedicated standby medical support for special events, and significant contractual agreements. These include a national ambulance contract with the Federal Emergency Management Agency (FEMA), as well as numerous partnerships with state agencies and health systems, all aimed at streamlining emergency medical response efforts. GMR Solutions serves a diverse client base, encompassing hospital systems of all sizes (from large regional networks to smaller independent facilities), local communities, healthcare payors, public health organizations, and various governmental entities at local, state, and federal levels.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)		FY 2025 12/31/2025
Total Revenue		5,740
Cost of Goods Sold Incl. D&A		3,507
Gross Profit		2,233
Selling, General and Administrative Excl. Other		192
Research and Development		0
Other Operating Expense		1,217
Operating Income		824
Interest Expense		423
Unusual Expense		—
Non-Operating Income (Expense)		-85
Net Income Before Taxes		317
Income Taxes		110
Consolidated Net Income		206
Net Income From Continuing Operations		206
Net Income		206
EPS (Recurring)		0.16
EPS (Basic, Before Extraordinaries)		0.16
EPS (Diluted)		0.16
EBITDA		1,069
Other After Tax Adjustments		—
Stock Option Compensation Expense		—
Price To Earnings Ratio		—
Price To Sales Ratio		—
Gross Margin		38.90
Operating Margin		14.36
Net Margin		3.59
Shares Outstanding		223
Market Capitalization		—
Operating Lease Expense		—

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Van Horne Edward	President & COO	Sep 14 '26	Sale	12.20	262,278	3,199,792	575,004	Sep 15
Tierney Brian Scott	EVP & CFO	Sep 14 '26	Option Exercise	7.20	42,500	306,000	851,470	Sep 15
Tierney Brian Scott	EVP & CFO	Sep 14 '26	Sale	12.20	265,794	3,242,687	554,955	Sep 15
Loporcaro Nicola	Chairman & CEO	Sep 14 '26	Sale	12.20	1,457,102	17,776,644	2,855,580	Sep 15
Jacoba Lisa	EVP & CHRO	Sep 14 '26	Sale	12.20	92,680	1,130,696	198,603	Sep 15
Hall Jessica	Chief Accounting Officer	Sep 14 '26	Sale	12.20	23,687	288,981	62,566	Sep 15
COOK THOMAS A A	EVP, GC & Secretary	Sep 14 '26	Sale	12.20	251,882	3,072,960	675,686	Sep 15
Jacoba Lisa	EVP & CHRO	May 14 '26	Buy	15.00	1,000	15,000	291,283	May 15

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.